MetLife, Inc. $MET Stake Cut by NewEdge Advisors LLC

NewEdge Advisors LLC cut its holdings in shares of MetLife, Inc. (NYSE:MET) by 8.0% in the first quarter, HoldingsChannel reports. The fund owned 61,624 shares of the financial services provider’s stock after selling 5,327 shares during the quarter. NewEdge Advisors LLC’s holdings in MetLife were worth $4,358,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Optiver Holding B.V. grew its position in MetLife by 3,007.7% during the first quarter. Optiver Holding B.V. now owns 4,040 shares of the financial services provider’s stock valued at $286,000 after purchasing an additional 3,910 shares in the last quarter. Keel Point LLC purchased a new position in shares of MetLife during the 1st quarter valued at $250,000. Alpine Woods Capital Investors LLC acquired a new position in shares of MetLife in the first quarter worth $3,925,000. Glenmede Trust Co. NA raised its holdings in shares of MetLife by 31.3% during the first quarter. Glenmede Trust Co. NA now owns 44,958 shares of the financial services provider’s stock worth $3,179,000 after acquiring an additional 10,712 shares in the last quarter. Finally, Axiom Investment Management LLC acquired a new stake in MetLife during the first quarter valued at $42,000. Institutional investors and hedge funds own 94.99% of the company’s stock.

Analysts Set New Price Targets

MET has been the topic of several research reports. TD Cowen upped their target price on MetLife from $87.00 to $105.00 and gave the stock a “buy” rating in a research report on Wednesday, July 22nd. Wall Street Zen downgraded MetLife from a “buy” rating to a “hold” rating in a report on Saturday, May 9th. Keefe, Bruyette & Woods lifted their target price on shares of MetLife from $105.00 to $108.00 and gave the company an “outperform” rating in a research note on Tuesday. Atlantic Securities set a $103.00 target price on shares of MetLife in a research report on Wednesday, July 15th. Finally, Mizuho increased their price target on shares of MetLife from $95.00 to $102.00 and gave the stock an “outperform” rating in a research note on Thursday, July 9th. One investment analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $101.07.

MetLife Stock Performance

Shares of NYSE MET opened at $96.78 on Wednesday. The business’s 50-day simple moving average is $90.68 and its 200-day simple moving average is $81.14. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.20 and a current ratio of 0.20. MetLife, Inc. has a 52 week low of $67.33 and a 52 week high of $100.93. The firm has a market cap of $62.27 billion, a price-to-earnings ratio of 18.54, a P/E/G ratio of 0.75 and a beta of 0.78.

MetLife (NYSE:MET) last posted its earnings results on Wednesday, August 5th. The financial services provider reported $2.43 earnings per share for the quarter, topping the consensus estimate of $2.30 by $0.13. The firm had revenue of $13.52 billion during the quarter, compared to analyst estimates of $19.67 billion. MetLife had a return on equity of 23.39% and a net margin of 4.57%.The company’s revenue for the quarter was up 10.5% on a year-over-year basis. During the same period in the previous year, the company earned $2.02 EPS. As a group, equities research analysts expect that MetLife, Inc. will post 9.75 earnings per share for the current fiscal year.

MetLife Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 8th. Stockholders of record on Tuesday, August 4th will be paid a $0.5925 dividend. This represents a $2.37 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date is Tuesday, August 4th. MetLife’s payout ratio is presently 45.40%.

MetLife declared that its Board of Directors has approved a stock repurchase program on Wednesday, August 5th that permits the company to repurchase $3.00 billion in outstanding shares. This repurchase authorization permits the financial services provider to buy up to 4.8% of its stock through open market purchases. Stock repurchase programs are often a sign that the company’s board of directors believes its stock is undervalued.

Trending Headlines about MetLife

Here are the key news stories impacting MetLife this week:

• Positive Sentiment: JPMorgan raised its price target for MetLife from $106 to $108 and maintained an “overweight” rating. The new target implies approximately 11.6% upside from the referenced $96.78 level, signaling continued confidence in the insurer’s earnings and valuation. Benzinga report
• Positive Sentiment: Keefe, Bruyette & Woods also increased its price target from $105 to $108 and reaffirmed an “outperform” rating. The second target increase reinforces the constructive analyst view of MetLife’s prospects. Benzinga report Ticker Report article
• Neutral Sentiment: MetLife Pet Insurance announced a partnership with America’s VetDogs to help co-raise a future service dog for a veteran or first responder with disabilities. The initiative may enhance brand reputation and community engagement, but is unlikely to materially affect near-term financial results. MetLife Pet Insurance and America’s VetDogs partnership
• Neutral Sentiment: MetLife highlighted benefits and employee well-being in its 2025 Sustainability Report. The disclosure may support long-term stakeholder and corporate-responsibility goals, though it is not an immediate earnings catalyst. MetLife 2025 Sustainability Report

About MetLife

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.